Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells

Keyphrases

• Human Endothelial Cells 100%
• α-galactosylceramide (α-GalCer) 100%
• PECAM-1 72%
• Mesothelioma Cells 18%
• Morpholino 9%
• Inflammatory Vascular Diseases 9%
• GalT 9%
• RNA-mediated Silencing 9%
• Glucosylceramide 9%
• Glycosphingolipids 9%
• Factor-driven 9%
• Endogenous Expression 9%
• Phenotypic Change 9%
• Vascular Tumor 9%
• Vascular Endothelial Growth Factor Receptor Inhibitor 9%
• Human Platelets 9%
• Structurally Related Compounds 9%
• Phospholipase A2 Inhibitor 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Lactosylceramide 100%
• Platelet Endothelial Cell Adhesion Molecule 1 72%
• Mesothelioma 9%
• 2 Decanoylamino 3 Morpholino 1 Phenyl 1 Propanol 9%
• Ceramide Glucosyltransferase 9%
• Glycosphingolipid 9%
• Phospholipase A 9%
• Vascular Tumor 9%
• Glucosylceramide 9%
• Small Interfering RNA 9%

Biochemistry, Genetics and Molecular Biology

• Lactosylceramide 100%
• Cell Adhesion Molecule 1 72%
• Receptor Tyrosine Kinase Inhibitors 9%
• 1-Propanol 9%
• Morpholino 9%
• Glycosphingolipid 9%